Phase 2 Study of INBRX-109 in Conventional Chondrosarcoma
Condition: Conventional Chondrosarcoma Interventions: Drug: INBRX-109; Drug: Placebo Sponsor: Inhibrx, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2021 Category: Research Source Type: clinical trials
Neutrophils in Bone Sarcomas
Condition: Osteosarcoma, Chondrosarcoma Intervention: Other: No intervention Sponsor: Université de Reims Champagne-Ardenne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2021 Category: Research Source Type: clinical trials